- Home
- DMRA vs LU Comparison
DMRA vs LU Comparison
Compare DMRA & LU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DMRA | LU |
|---|---|---|
| Founded | 2011 | 2005 |
| Country | United States | China |
| Employees | 7 | 33163 |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.6B |
| IPO Year | 2020 | 2020 |
Fundamental Metrics
Financial Performance| Metric | DMRA | LU |
|---|---|---|
| Price | $24.60 | $1.89 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 1 |
| Target Price | ★ $43.00 | $2.00 |
| AVG Volume (30 Days) | 279.5K | ★ 1.1M |
| Earning Date | 05-11-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $22.52 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $16.50 | $1.73 |
| 52 Week High | $28.76 | $4.57 |
Technical Indicators
Market Signals| Indicator | DMRA | LU |
|---|---|---|
| Relative Strength Index (RSI) | 48.32 | 43.00 |
| Support Level | $22.71 | $1.73 |
| Resistance Level | $28.00 | $2.05 |
| Average True Range (ATR) | 1.84 | 0.06 |
| MACD | -0.13 | 0.01 |
| Stochastic Oscillator | 52.01 | 21.43 |
Price Performance
Historical ComparisonAbout DMRA Damora Therapeutics Inc. Common Stock
Damora Therapeutics Inc is a biotechnology company that aims to fundamentally redefine care for people with hematologic disorders. The group is advancing a new generation of biologics to treat mutant calreticulin-driven myeloproliferative neoplasms, including essential thrombocythemia and myelofibrosis, where there is cruicial medical need for disease-modifying treatments. Its goal is to rapidly bring forward optimized therapies with broad mutation coverage and exceptional convenience to dramatically improve patient outcomes. The group's pipeline products are DMR-001, DMR-002, DMR-003, and GB3226.
About LU Lufax Holding Ltd each representing two (2)
Lufax Holding Ltd is an investment holding company, together with its consolidated subsidiaries, engaged in core retail credit and enablement business to both borrowers and institutions in the People's Republic of China. The group's segments are Lending-related business, which provides Retail credit and enablement, consumer finance loans, and Digital banking business, including Retail banking and SME banking.